Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.-Reference-Cited by-同舟云学术

Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.

Published:1993-10 Issue:29 Volume:268 Page:21478-21481
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Lechleider R.J.,Sugimoto S,Bennett A.M.,Kashishian A.S.,Cooper J.A.,Shoelson S.E.,Walsh C.T.,Neel B.G.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference34 articles.

1. Signal transduction by receptors with tyrosine kinase activity

2. Oncogenes and signal transduction

3. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins

4. SH2 and SH3 domains: From structure to function

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms;American Journal of Hematology;2024-03-05

2. SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment;Cancer Discovery;2023-09-08

3. A comprehensive review of SHP2 and its role in cancer;Cellular Oncology;2022-09-06

4. Grb2 binding induces phosphorylation-independent activation of Shp2;Communications Biology;2021-04-01

5. Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state;Computational and Structural Biotechnology Journal;2021